CRISPR Therapeutics AG (CRSP) has the following price history information. Looking back at CRSP historical stock prices for the last five trading days, on April 29, 2024, CRSP opened at $54.09, traded as high as $55.62 and as low as $54.00, and closed at $54.83. Trading volume was a total of 1.47M shares. On April 30, 2024, CRSP opened at $53.90, traded as high as $54.44 and as low as $52.73, and closed at $52.99. Trading volume was a total of 1.12M shares. On May 01, 2024, CRSP opened at $53.16, traded as high as $55.97 and as low as $52.74, and closed at $53.81. Trading volume was a total of 1.34M shares. On May 02, 2024, CRSP opened at $54.48, traded as high as $55.34 and as low as $53.98, and closed at $55.07. Trading volume was a total of 1.00M shares. On May 03, 2024, CRSP opened at $56.70, traded as high as $58.45 and as low as $55.57, and closed at $55.89. Trading volume was a total of 1.43M shares.

CRSP Historical Stock Prices By Date:

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 20142015201620172018201920202021202220232024

Below, we examine the compound annual growth rate — CAGR for short — of an investment into CRISPR Therapeutics AG shares, starting with a $10,000 purchase of CRSP, and working forward through the historical stock price information to today.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	10/20/2016
End date:	05/03/2024
Start price/share:	$13.94
End price/share:	$55.89
Dividends collected/share:	$0.00
Total return:	300.93%
Average Annual Total Return:	20.22%
Starting investment:	$10,000.00
Ending investment:	$40,086.91
Years:	7.54

CRSP Historical Price Range
Date	Open	High	Low	Close	Volume
04/29/2024	$54.09	$55.62	$54.00	$54.83	1.47M
04/30/2024	$53.90	$54.44	$52.73	$52.99	1.12M
05/01/2024	$53.16	$55.97	$52.74	$53.81	1.34M
05/02/2024	$54.48	$55.34	$53.98	$55.07	1.00M
05/03/2024	$56.70	$58.45	$55.57	$55.89	1.43M

About CRISPR Therapeutics AG

CRISPR Therapeutics is a gene editing company focused on the development of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) based therapeutics. CRISPR/Cas9 is a technology for gene editing, the process of altering specific sequences of genomic DNA. Co. is developing several gene-edited allogeneic cell therapy programs. Co.'s main product candidate, CTX001, is an investigational ex vivo CRISPR gene-edited therapy that is being evaluated for patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce fetal hemoglobin in red blood cells.

CRSP Historical Closing Prices
Date	Close
04/29/2024	$54.83
04/30/2024	$52.99
05/01/2024	$53.81
05/02/2024	$55.07
05/03/2024	$55.89

CRSP Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.